Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |